Get the Stockscreener App
80.04
6.59%
-5.65
After Hours:
80.03
-0.01
-0.01%
Solventum Corp stock is traded at $80.04, with a volume of 1.41M.
It is down -6.59% in the last 24 hours and down -3.54% over the past month.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
See More
Previous Close:
$85.69
Open:
$85.29
24h Volume:
1.41M
Relative Volume:
1.36
Market Cap:
$13.88B
Revenue:
$8.31B
Net Income/Loss:
$379.00M
P/E Ratio:
37.06
EPS:
2.16
Net Cash Flow:
$385.00M
1W Performance:
-3.75%
1M Performance:
-3.54%
6M Performance:
+8.46%
1Y Performance:
+16.83%
1-Day Range:
$79.60
$85.47
1-Week Range:
$79.60
$86.36
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
80.04 | 14.86B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
561.82 | 203.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
201.51 | 57.76B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.98 | 39.72B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
254.64 | 37.64B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.85 | 33.63B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Institutional investors control 73% of Solventum Corporation (NYSE:SOLV) and were rewarded last week after stock increased 9.0% - simplywall.st
Solventum Simplifies Dental Care with Advanced Fluoride Innovation - MSN
Will Solventum Corporation stock gain from strong economy2025 Fundamental Recap & Weekly Sector Rotation Insights - ulpravda.ru
Why Solventum Corporation (KB7) stock signals breakout potential2025 Macro Impact & Fast Moving Trade Plans - ulpravda.ru
Market Moves: Can Solventum Corporation stock retain market dominanceJuly 2025 Catalysts & Safe Entry Zone Tips - ulpravda.ru
Is Solventum Corporation (KB7) stock considered safe haven2025 Price Targets & Fast Entry Momentum Trade Alerts - ulpravda.ru
Assessing Solventum: Insights From 4 Financial Analysts - Benzinga
SOLV Stock: Stifel Raises Price Target to $105, Maintains Buy Ra - GuruFocus
Solventum stock price target raised to $105 from $88 at Stifel By Investing.com - Investing.com South Africa
Solventum stock price target raised to $105 from $88 at Stifel - Investing.com Australia
Is Solventum stock outperforming the Nasdaq? - MSN
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
AI @ HLTH: Inside Solventum’s AI Healthcare Strategy - HLTH
Solventum Advances Orthodontic Treatment by Helping Shape Modern Orthodontics - Digital Journal
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Key sale, acquisition helped 3M spinoff, Solventum, turn around in 2025 - Star Tribune
Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? - Yahoo Finance
Harbor Capital Advisors Inc. Has $1.31 Million Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio - sharewise.com
Strong Tower Advisory Services Buys 16,851 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Completes Acquisition of Acera Surgical - The Malaysian Reserve
Solventum completes acquisition of Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Closes Acquisition of Acera Surgical - marketscreener.com
Solventum completes Acera Surgical acquisition - MassDevice
Solventum completes acquisition of Acera Surgical for $725 million - Investing.com India
Solventum is the top performing healthcare supplies stock YTD - MSN
Solventum is the top performing healthcare supplies stock YTD (SOLV:NYSE) - Seeking Alpha
How Investors Are Reacting To Solventum (SOLV) Expert Guidance Expanding Use Of Prevena ciNPT Dressings - simplywall.st
Wedge Capital Management L L P NC Sells 64,461 Shares of Solventum Corporation $SOLV - MarketBeat
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Argus Research Adjusts Solventum Price Target to $100 From $90, Maintains Buy Rating - marketscreener.com
Assenagon Asset Management S.A. Boosts Position in Solventum Corporation $SOLV - MarketBeat
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy - Finviz
New surgery guidelines expand use of vacuum dressings to protect incisions - Stock Titan
Piper Sandler names Solventum stock its 2026 top idea, maintains $98 target - Investing.com Nigeria
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):